Clinical trial
Evaluation of a Novel Skin Care Product for the Management of Acute Radiodermatitis in Breast Cancer Patients
NCT04929808 is registered in ClinicalTrials.gov with Jessa Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a Novel Skin Care Product for the Management of Acute Radiodermatitis in Breast Cancer Patients
- Lead sponsor
- Jessa Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2022
- Completion date
- June 13, 2023
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
radiation dermatitis, radiodermatitis; acute